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Abstract
Background: By altering specific developmental signaling pathways that are necessary for fetal lung development,
perinatal nicotine exposure affects lung growth and differentiation, resulting in the offsprings’ predisposition to
childhood asthma; peroxisome proliferator-activated receptor gamma (PPARg) agonists can inhibit this effect.
However, whether the perinatal nicotine-induced asthma risk is restricted to nicotine-exposed offspring only;
whether it can be transmitted to the next generation; and whether PPARg agonists would have any effect on this
process are not known.
Methods: Time-mated Sprague Dawley rat dams received either placebo or nicotine (1 mg/kg, s.c.), once daily
from day 6 of gestation to postnatal day (PND) 21. Following delivery, at PND21, generation 1 (F1) pups were
either subjected to pulmonary function tests, or killed to obtain their lungs, tracheas, and gonads to determine the
relevant protein markers (mesenchymal contractile proteins), global DNA methylation, histone 3 and 4 acetylation,
and for tracheal tension studies. Some F1 animals were used as breeders to generate F2 pups, but without any
exposure to nicotine in the F1 pregnancy. At PND21, F2 pups underwent studies similar to those performed on F1
pups.
Results: Consistent with the asthma phenotype, nicotine affected lung function in both male and female F1 and
F2 offspring (maximal 250% increase in total respiratory system resistance, and 84% maximal decrease in dynamic
compliance following methacholine challenge; P < 0.01, nicotine versus control; P < 0.05, males versus females; and
P > 0.05, F1 versus F2), but only affected tracheal constriction in males (51% maximal increase in tracheal
constriction following acetylcholine challenge, P < 0.01, nicotine versus control; P < 0.0001, males versus females;
P > 0.05, F1 versus F2); nicotine also increased the contractile protein content of whole lung (180% increase in
fibronectin protein levels, P < 0.01, nicotine versus control, and P < 0.05, males versus females) and isolated lung
fibroblasts (for example, 45% increase in fibronectin protein levels, P < 0.05, nicotine versus control), along with
decreased PPARg expression (30% decrease, P < 0.05, nicotine versus control), but only affected contractile proteins
in the male trachea (P < 0.05, nicotine versus control, and P < 0.0001, males versus females). All of the nicotine-
induced changes in the lung and gonad DNA methylation and histone 3 and 4 acetylation were normalized by
the PPARg agonist rosiglitazone except for the histone 4 acetylation in the lung.
Conclusions: Germline epigenetic marks imposed by exposure to nicotine during pregnancy can become
permanently programmed and transferred through the germline to subsequent generations, a ground-breaking
finding that shifts the current asthma paradigm, opening up many new avenues to explore.
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Background
Asthma is a major public health problem [1,2]. It is the
most common chronic disease of childhood [3,4], result-
ing in a significant medical burden and the resultant
healthcare costs [5,6]. The burden of this disease is
increasing rapidly, with the most striking increases seen
among children, the prevalence rates in some popula-
tions being greater than 30% [7]. Although a multitude
of causes contribute to childhood asthma, maternal
smoking during pregnancy is a well-established contri-
butor [8-13], and it is a major modifiable risk factor, the
elimination of which could significantly reduce the pre-
valence of childhood asthma. However, given that the
tobacco industry continues to spend billions of dollars
on advertising to attract young smokers, it is unlikely
that the problem of smoking during pregnancy will go
away any time soon [14]. Approximately 250,000,000
women smoke daily world-wide. Twelve percent of US
women still continue to smoke during pregnancy, result-
ing in the births of at least 400,000 smoke-exposed
infants per year in the US [15,16]. This aspect of the
smoking-induced asthma etiology is particularly impor-
tant since there is emerging evidence that, following in
utero exposure to maternal smoke, asthma can be trans-
mitted multigenerationally. For example, a questionnaire
in the Children’s Health Study from Southern California
reported that grandmaternal smoking during pregnancy
increases the risk of asthma in grandchildren regardless
of the presence of maternal smoking [17]. Yet there is
neither experimental evidence nor any mechanistic
explanation for this phenomenon. Using a well-estab-
lished rat model of in utero nicotine exposure for child-
hood asthma [18-20], we aimed to determine if in utero
nicotine exposure would transmit asthma to the second
generation offspring, and if epigenetic mechanism(s)
could be involved in this transmission.
The mechanism linking smoke/nicotine exposure during
pregnancy to multigenerational (MG) transmission of
asthma is unknown. Since transmission via the germline is
the most likely explanation for the non-genetic MG trans-
mission phenomenon, we rationalized that epigenetic
modifications of the germline explain MG transmission of
perinatal nicotine-induced asthma. For example, a change
in the organism’s environment, that is, smoke/nicotine
exposure (of the F0 generation), can result in modifica-
tions in gene expression through alterations in DNA
methylation, histone (H) modification, non-coding RNA,
and/or protein structure and assembly without changing
the DNA sequence of the F1 germline, which can be trans-
mitted to subsequent generations [21,22]. However,
whether epigenetic marks such as alterations in DNA
methylation and/or H modifications acquired in one gen-
eration can be inherited by the next generation is not
clear. While one study reported that the acquired DNA
methylation marks are not transmitted to subsequent gen-
erations [23], another study came to the opposite conclu-
sion [24]. We hypothesize that smoke/nicotine-induced
epigenetic marks can become permanently programmed
and transferred through the germline to subsequent gen-
erations, resulting in altered phenotypic changes at the cel-
lular and consequent organismal levels (for example,
asthma in the case of in utero smoke/nicotine exposure) in
the offspring over multiple subsequent generations, for
example, F2, F3, and so on.
Furthermore, the effect of the child’s gender on asthma
risk following perinatal exposure to cigarette smoke is
not clear since an increased risk in both boys [25] and
girls [26] has previously been reported. However, since
there is emerging evidence to suggest that finely-tuned
developmental programs, such as that of the lung, may
be sensitive to specific environmental challenges in a sex-
specific manner, particularly during the developmental
programming and gametogenesis stages [27], and since
maternal smoking is known to affect fetal growth more
profoundly in the male fetus [28], we also hypothesized
that there would be a sexual dimorphism in asthma risk
following in utero smoke exposure, with males being
more susceptible than females.
Methods
Materials
Nicotine bitartrate was acquired from Sigma-Aldrich (St.
Louis, MO, USA) and rosiglitazone (RGZ) from Cayman
Chemical (Chicago, IL, USA). DNA methylation (cat#: P-
1034-96), H3 (cat#: P-4008-96) and H4 (cat#: P-4009-96)
acetylation kits were obtained from Epigentek (Farming-
dale, NY, USA). All plasticware and culture media were
purchased from Corning (Corning, NY, USA) and Invi-
trogen, Inc. (San Deigo, CA, USA).
Animal model (Schematic 1)
Pathogen-free timed (embryonic day 0 = day of mating)
pregnant Sprague-Dawley F0 rats (200 to 250 g body
weight) were obtained from Charles River (Hollister, CA,
USA), and allowed to acclimatize until embryonic day 6
[see Additional File 1 for Schematic]. Dams were rando-
mized to receive placebo (diluent, normal saline), nico-
tine (1 mg/kg, s.c.) alone, or nicotine (1 mg/kg), and the
PPARg agonist RGZ (3 mg/kg, i.p.) in 100 μL volumes
once daily from embryonic day 6 to postnatal day (PND)
21. The dams were allowed free access to water and pair-
fed according to the previous day’s intake by the nicotine
group animals and were maintained in a 12:12-hour
light-dark cycle. Following delivery at term, the F1 pups
were allowed to breast feed ad libitum. At PND21 the
pups were either subjected to pulmonary function tests
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(PFTs) and then killed, or killed and their lungs and tra-
cheas collected for airway contractility protein levels,
fibroblast isolation, and tracheal tension studies. The
gonads were collected to determine epigenetic marks.
Some F1 animals were weaned at PND21 and maintained
as breeders to generate F2 rats, but without any exposure
to nicotine in the F1 pregnancy. At PND21, F2 animals
underwent studies similar to those performed on F1 ani-
mals. All studies were approved by the Los Angeles Bio-
medical Research Institutional Review Board and were
conducted in accordance with the National Institutes of
Health Guide for the Care and Use of Laboratory Animals.
The dose (1 mg/kg) chosen for the nicotine treatment
has previously been shown to result in an asthma phe-
notype in the offspring in a number of studies (reviewed
in [18]) and is comparable to the dose of nicotine to
which habitual smokers are exposed, that is, approxi-
mately 1 mg/kg/body weight [29]. As further support
for the doses of nicotine and RGZ used in this study,
pulmonary function changes induced following perinatal
exposure to 1 mg/kg/day nicotine, administered s.c.,
were recently shown to be blocked by the concomitant
i.p. administration of 3 mg/kg/day RGZ (20). It is also
important to note that this dose of RGZ has previously
been shown to block hyperoxia-induced neonatal lung
injury as well [30]. Two animals were used for each con-
dition per experiment, and each experiment was
repeated at least three times.
Lung fibroblast isolation
PND21 rat lung fibroblasts were cultured according to
previously described methods, with slight modifications
[30]. Briefly, the lungs were removed and put into Hanks’
balanced salt solution (HBSS) and chopped into small
pieces. The HBSS was decanted and 5 volumes of 0.05%
trypsin were added to the lung preparation. The lungs
were dissociated in a 37°C water bath using a Teflon stir-
ring bar to disrupt the tissue mechanically. Once the tis-
sue was dispersed into a unicellular suspension, the cells
were pelleted at 500 × g for 10 minutes at room tempera-
ture in a 50-mL polystyrene centrifuge tube. The super-
natant was decanted, and the pellet was resuspended in
minimal essential medium (MEM) containing 10% FBS
to yield a mixed cell suspension of approximately 3 × 108
cells, as determined using a Coulter particle counter
(Beckman-Coulter, Hayaleah, FL, USA). The cell suspen-
sion was then added to culture flasks (75 cm2) for 30 to
60 minutes to allow for the differential adherence of lung
fibroblasts. These cells are greater than 95% pure fibro-
blasts based upon vimentin-positive staining.
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Figure 1 Effect of perinatal nicotine exposure on mixed gender offspring pulmonary function. Compared to the control group, with
nicotine administration there was a significant increase in total airway resistance and a decrease in total compliance following Mch challenge in
both F1 and F2 rats of mixed gender even though the F2 rats were not exposed to any nicotine during the F1 gestation. Values are means ±
SE. n = 10 to 12 for each group. *P < 0.05, **P < 0.01, versus control. Mch, methacholine.
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Pulmonary function testing
Measurement of respiratory function was performed with
a plethysmograph for restrained animals (Buxco Inc, Troy,
NY, USA); the pups were deeply anesthetized and sedated
with ketamine (70 mg/kg, Bioniche Teoranta Inverin, Co.,
Galway, Ireland), and xylazine (7 mg/kg, Akorn, Inc., Dec-
atur, IL, USA), tracheostomized and ventilated. Rats were
exposed to increasing concentrations of aerosolized
methacholine (0, 1.25, 2.5, 5, 10, and 20 mg/ml) over a
period of 3 minutes. Lung resistance (Rrs) and dynamic
compliance (Cdyn) were plotted as a function of the
methacholine concentration administered.
Tracheal constriction studies
The trachea was excised en bloc immediately after sacrifice
and dissected free of connective tissue in ice-cold modified
Krebs-Ringer bicarbonate buffer (in mM: 118.3 NaCl, 4.7
KCl, 2.5 CaCl2, 1.2 MgSO4, 1.2 KH2PO4, 25.0 NaHCO3
and 11.1 glucose). Subsequently, an approximately 6 mm
tracheal ring was resected from the midsection and used
for tracheal tension studies. The tracheal ring was sus-
pended in an organ chamber filled with 10 ml of modified
Krebs-Ringer bicarbonate solution maintained at 37 ± 0.5°
C and aerated with 95% O2-5% CO2 (pH 7.4). Each ring
was suspended via two stirrups that were passed through
the lumen: one stirrup was anchored to the bottom of the
organ chamber and the other stirrup was connected to a
strain gauge (model FT03C, Grass Instrument, Quincy,
MA, USA) for the measurement of isometric force, as
described previously [20].
At the beginning of the experiment, each tracheal ring
was stretched to its optimal resting tension, which was
achieved by step-wise stretching in 0.1-g increments until
the contractile response to 100 mM KCl reached a plateau.
The optimal resting tension was measured, and then each
tracheal ring was allowed to equilibrate for one hour after
it was brought to its optimal resting tension. The effects of
acetylcholine were determined at least 30 minutes after
the administration of nitro-L-arginine (1 × 10-4 M, an
inhibitor of nitric oxide synthase). In all experiments,
indomethacin (1 × 10-5 M) was added to the bath to pre-
vent the possible interference by prostanoids.
Western blot
Western blot analysis for fibronectin, a-smooth muscle
actin (a-SMA), calponin, collagens I and III, nicotinic
acetylcholine receptors a3 and a7, and PPARg were per-
formed as described previously [20].
Real Time Reverse Transcription-Polymerase Chain
Reaction
RT-PCR was performed as previously described [19,31].
Global DNA methylation
Genomic DNA from lungs, testes, and ovaries was isolated
using QIAamp DNA Mini Kit (Qiagen, Valencia, CA,
USA, Cat. No.: 51304) and the DNA concentration was
determined using a NanoDrop2000. Global DNA methyla-
tion was quantified using a MethylFlash Methylated DNA
Quantification Kit (Epigentek, Cat. No.: P-1034) according
to the manufacturer’s instructions. Briefly, DNA is bound
to strip wells that are specifically treated to have high
DNA affinity. The methylated fraction of DNA is detected
using capture and detection antibodies, and then quanti-
fied colorimetrically by reading the absorbance at 450 nm
in a Wallac 1420 Multilabel Counter. The amount and
Resistance Compliance
**
**
**
**
**
##
##
##
##
##
0
50
100
150
200
250
300
350
0 1.25 2.5 5 10 20
Methacholine (mg/ml)
R
rs
 (A
rb
itr
ar
y 
U
ni
t) Control
Nicotine
Nicotine + RGZ
****
**
**
**
##
##
##
##
##
0
20
40
60
80
100
120
0 1.25 2.5 5 10 20
Methacholine (mg/ml)
C
dy
n 
(A
rb
itr
ar
y 
U
ni
t)
Control
Nicotine
Nicotine + RGZ
Figure 2 Effect of rosiglitazone (RGZ) on perinatal nicotine exposure-induced alterations in mixed gender offspring pulmonary
function. Compared to the control group, with nicotine administration there was a significant increase in resistance and a significant decrease
in compliance of the lung following a Mch challenge, both of which were blocked by concomitant RGZ administration. Values are means ± SE.
n = 10 to 12 for each group. **P < 0.01, versus control; ##P < 0.01, versus nicotine group. Mch, methacholine.
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percentage of methylated DNA (5-mC) in the total DNA
extract was calculated based on a standard curve gener-
ated using a methylated DNA positive control.
Global histone H3 and H4 acetylation
Histone protein from lungs, testes, and ovaries was
extracted using an EpiQuik Total Histone Extraction Kit
(Epigentek, Cat. No.: OP-0006), and histone protein con-
centration was measured by the Bradford method, using
BSA as the standard. Global histone H3 and H4 acetyla-
tion was quantified using an EpiQuik Global Histone H3
Acetylation Assay Kit (Epigentek, Cat. No.: P-4008) and an
EpiQuik Global Histone H4 Acetylation Assay Kit (Epi-
gentek, Cat. No.: P-4009) according to the manufacturer’s
instructions. Briefly, the histone proteins are stably spotted
on the strip wells. The acetylated histone H3 and H4 are
recognized with high-affinity antibodies against them. The
amount of acetylated H3 and H4 are quantified through a
horseradish peroxidase-conjugated secondary antibody-
color development system, and the absorbance at 450 nm
is read in a Wallac 1420 Multilabel Counter. The amount
of acetylated histone H3 and H4 in the total histone pro-
tein was calculated according to a standard curve gener-
ated using acetylated histone H3 or H4.
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Figure 3 Effect of perinatal nicotine exposure on male and female offspring pulmonary function. Compared to the control group, with
nicotine administration there were significant increases in resistance and decreases in compliance of the lung following Mch challenge in F1 and F2
male (A) and female (B) rats even though the F2 pups were not exposed to any nicotine during gestation. Values are means ± SE. n = 5 to 6 for each
group. *P < 0.05, **P < 0.01 versus control. Mch, methacholine.
Rehan et al. BMC Medicine 2012, 10:129
http://www.biomedcentral.com/1741-7015/10/129
Page 5 of 14
Statistics
The data for analysis were obtained from at least three
independent sets of experiments. Analysis of variance
(ANOVA) for multiple comparisons with Bonferroni
post-hoc analysis and Student’s t-test, as indicated, were
used, and P < 0.05 was considered to indicate significant
differences among the experimental groups.
Results
We initially determined the effect of nicotine on pulmon-
ary function in response to a graded methacholine chal-
lenge. Compared to the control group, with perinatal
nicotine exposure to F0 dams (Figure 1) there was a signif-
icant increase in total airway Rrs, and a decrease in total
airway Cdyn of the respiratory system, not only in F1 rats
[20], but also in F2 rats (P < 0.01 versus control for both
Rrs and Cdyn), even though the F2 rats were not exposed
to nicotine. In accord with our recently published data on
F1 rats [20], RGZ treatment blocked the nicotine-induced
increase in Rrs and decrease in Cdyn in F2 rats (P < 0.01
versus nicotine for both Rrs and Cdyn) (Figure 2).
We subsequently analyzed the effects of nicotine expo-
sure on PFT’s in male and female offspring separately
(Figure 3a and 3b). Following a methacholine challenge,
perinatal nicotine exposure only to F0 dams caused a sig-
nificant increase in Rrs and a decrease in Cdyn in both
the males and females of the F1 and F2 generations (P <
0.05, males versus females, for both Rrs and Cdyn).
Having determined the effect of in utero nicotine expo-
sure on the F1 and F2 offspring whole respiratory systems,
we examined the effect of nicotine on tracheal rings iso-
lated from F1 and F2 offspring (Figure 4). Nicotine admin-
istration caused a significant increase in tracheal
constriction in response to acetylcholine only in the males
of both the F1 and F2 generations (P < 0.01 versus control).
Since we had previously determined that the nicotine
exposure of F0 dams increased the expression of lung con-
tractile proteins and inhibited PPARg expression in both
the whole lung and isolated alveolar interstitial fibroblasts
of F1 rats [20], we next determined this effect in the F2
offspring. We found that the protein levels of fibronectin,
a-SMA, calponin, and collagens I and III, and nicotinic
acetylcholine receptors a3 and a7 were all increased sig-
nificantly in the whole lung lysates of both the male
(Figure 5a and 5b) and female F2 (P < 0.05 versus control
for all) (Figure 6a and 6b) rats. In contrast, at the tracheal
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Figure 4 Effect of perinatal nicotine exposure on acetylcholine tracheal constriction response in F1 and F2 offspring. Compared to the
control group, with nicotine administration there was a significant increase in tracheal constriction in response to acetylcholine only in the
males of both the F1 and F2 generations. Values are means ± SE; * P < 0.05, ** P < 0.01, versus control group; n = 5 to 6.
Rehan et al. BMC Medicine 2012, 10:129
http://www.biomedcentral.com/1741-7015/10/129
Page 6 of 14
level the expression of fibronectin, a-SMA, calponin, col-
lagen I, nicotinic acetylcholine receptors (nAChR) a3 and
a7 were increased only in males (P < 0.05 versus control)
(Figure 7a and 7b). In line with our recently published
data, the expression of fibronectin was increased, and that
of PPARg was decreased, at both the mRNA and protein
levels in the alveolar interstitial fibroblasts isolated from
the lungs of F2 rats (P < 0.05 versus control) (Figure 8).
To determine the likely mechanism of nicotine-
induced transmission of asthma to the second genera-
tion offspring, we next determined the effect of F0 nico-
tine exposure on global DNA methylation and histone
acetylation in the lungs and gonads of the F1 rats. We
observed that with nicotine administration global DNA
methylation increased in the testes (P < 0.01), decreased
in the ovaries (p < 0.05), but did not change in the
lungs (Figure 9a); H3 acetylation increased in the lungs
(P < 0.01) and testes (P < 0.05), but did not change in
the ovaries (Figure 9b); H4 acetylation decreased in the
lungs (P < 0.01) while it increased in the testes (P <
0.01) and ovaries (P < 0.05) (Figure 9c). Further, we
determined if the nicotine effects on histone methylation
and acetylation were affected by RGZ, which has been
shown to normalize the structural and functional effects
of nicotine on the offspring lung phenotype at F1 [20].
The nicotine-induced increase in lung H3 acetylation
was blocked (Figure 9b) by RGZ treatment, whereas
there was no effect on global DNA methylation (Figure
9a) or on the nicotine-induced decrease in H4 acetylation
(Figure 9c), suggesting a central role of H3 acetylation in
mediating nicotine’s effects on the pulmonary phenotype.
Finally, it is reassuring to note that perinatal exposure of
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Figure 5 Effect of perinatal nicotine exposure on mesenchymal protein markers of airway reactivity and nicotinic acetylcholine receptors
a3 and a7 in lungs of male F2 rats. Compared to the control group, with nicotine administration the protein levels of fibronectin, a-SMA, calponin,
and collagens I and III (A) and nicotinic acetylcholine receptors a3 and a7 (B) increased significantly. Upper panels show representative Western blots
for these markers and glyceraldehyde 3-phosphate dehydrogenase (GAPDH). Lower panels show the densitometric values of the markers normalized
to GAPDH. Values are means ± SE. n = 6 for each group. * P < 0.05, **P < 0.01, versus control group. a-SMA, a-smooth muscle actin.
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the gonads to RGZ by itself did not result in any signifi-
cant changes in global gonadal DNA methylation or in H3
and H4 acetylation (Figure 10).
Discussion
In the present series of experiments we have observed
significant effects of nicotine treatment on lung function
in the next two generations, affecting both the male and
female offspring. In sharp contrast, nicotine treatment
only affected the tracheal contractility of the male off-
spring. The functional effects of nicotine on the naive
offspring were accompanied by increased expression of
contractile proteins in the whole lung, as well as in the
associated isolated lung fibroblasts, accompanied by
decreased PPARg expression. These nicotine-induced
changes in lung function and mesenchymal protein
expression, accompanied by decreased PPARg expres-
sion, are consistent with the effect of nicotine on myofi-
broblast differentiation [32]. Even more importantly,
along with the normalization of the asthma phenotype
in the F1 and F2 offspring, most of the nicotine-induced
lung and gonadal epigenetic changes were also normal-
ized. For example, nicotine-induced increases in H3
acetylation in the lung, DNA methylation and H4 acety-
lation in the testis, and the decrease in DNA methyla-
tion and increase in H4 acetylation in the ovaries of F1
offspring were normalized by RGZ treatment, but it had
no effect on lung H4 acetylation, providing further
mechanistic specificity regarding the nature of the epige-
netic mechanism. Given these insights, we will extend
these studies to F3 and F4 generation offspring in future
studies.
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Figure 6 Effect of perinatal nicotine exposure on mesenchymal protein markers of airway reactivity and nicotinic acetylcholine
receptors a3 and a7 in lungs of female F2 rats. Compared to the control group, with nicotine administration the protein levels of
fibronectin, a-SMA, calponin, and collagens I and III (A) and nicotinic acetylcholine receptors a3 and a7 (B) increased significantly. Upper panels
show representative Western blots for the markers and GAPDH. Lower panels show the densitometric values for these markers normalized to
GAPDH. Values are means ± SE. n = 6 for each group. * P < 0.05, **P < 0.01, versus control group. GAPDH, glyceraldehyde 3-phosphate
dehydrogenase; a-SMA, a-smooth muscle actin.
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Since ruling out genetic and environmental confoun-
ders is extremely difficult in humans, there is only scant
evidence for MG epigenetic effects for any condition in
humans [33]; and in fact, there is none for asthma.
Recently emerging evidence suggests that the phenotype
of an individual is the cumulative result of complex
interactions between the genotype and its current, past
and ancestral environments [27,34]. Therefore, it is logi-
cal to speculate a role for ancestral cigarette smoke
exposure in the child’s asthma predisposition. Yet, as
pointed out above, there is no evidence for this, other
than the data from the Children’s Health Study from
Southern California [17].
In contrast to other species, the evidence for fetal pro-
gramming as a mode of MG transmission of traits in
humans is very limited. For example, mothers from the
Dutch Hunger Winter who were exposed to famine as
fetuses delivered offspring of lower birth weights than
those with no fetal exposure to famine, although this was
not confirmed in a subsequent study [35]. There is also evi-
dence of increased morbidity and mortality associated with
parental and grandparental nutritional status, suggesting a
role for fetal programming, possibly via epigenetic mechan-
isms to account for the MG effects [21,36,37]. In contrast
to the very limited data in humans, in a variety of animal
models gestational exposure to carcinogens, endocrine dis-
ruptors, and other toxins has been shown to have MG
effects [38-40].
The present study is groundbreaking in our understand-
ing of the mechanisms potentially involved in the trans-
mission of epigenetic human diseases, which to date have
only been speculated, albeit based on strong epidemiologic
grounds [41]. The observation that nicotine exposure in
utero affects the F1 offspring DNA methylation of the
testes and ovaries, and that H3 acetylation was increased
in the lungs and testes of F1 male offspring in association
with male-specific increased tracheal constriction is the
first demonstration of an epigenetic effect of nicotine on
both gametocytes and somatocytes. Furthermore, the spe-
cific inhibition of this effect of nicotine on H3 acetylation
by RGZ, which we have previously shown to block the
nicotine-induced asthma phenotype in F1 offspring [20],
provides a unique molecular genetic insight to the MG
mechanism of nicotine action. It must be borne in mind,
however, that these offspring’s developing gonads had
been exposed to nicotine in utero, leaving open the possi-
bility that the effect was not a bona fide transgenerational
effect, but was rather only MG. However, the transmission
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Figure 7 Effect of perinatal nicotine exposure on mesenchymal protein markers of airway reactivity and nicotinic acetylcholine
receptors a3 and a7 in tracheas of male and female F2 rats. Compared to the control group, with nicotine administration the protein
levels of fibronectin, a-SMA, calponin, and collagens I and III increased significantly in male (A) but not in female rats (B). Upper panels show
representative Western blots for these markers and GAPDH. Lower panels show the densitometric values of these markers normalized to GAPDH.
Values are means ± SE. n = 6 for each group. * P < 0.05, **P < 0.01, versus control group. GAPDH, glyceraldehyde 3-phosphate dehydrogenase;
a-SMA, a-smooth muscle actin.
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of the asthma phenotype to the F2 generation, both struc-
turally and functionally, and its prevention by a speci-
fically-targeted molecular intervention is the first
unequivocal demonstration of MG transmission of an epi-
genetically-mediated effect on the offspring phenotype.
The fact that the phenotypic effect was on asthma, a
well-recognized epidemiologic example of epigenetic
transmission of the cause of a public health epidemic,
makes this series of experiments all the more significant
and noteworthy. This, and the recent finding that even
‘thirdhand smoke’ can induce the asthma phenotype [42],
portends new and rational ways of thinking about effec-
tively coping with the health hazards that abound all
around us [43,44].
At first glance, it might seem surprising that the nicotine
effect on the asthma phenotype is sex-specific. However,
there is a documented association between gender and air-
way size, first referred to as dysanapsis by Mead [45], in
which he showed that boys and women had self-similar
airway structure that was distinctly different from that of
men. Those data suggest that androgens may differentially
affect airway development. We have previously shown that
androgens affect the rate of lung development in rabbits
and rats by inhibiting the glucocorticoid-induced differen-
tiation of lung fibroblasts [46], consistent with their effect
on lipofibroblast differentiation [47], which determines
lung development [48]. The airway narrowing of dysanap-
sis has also been shown to be associated with asthma [49].
Therefore, androgens may precipitate asthma through a
common genetic mechanism, since they, like nicotine,
stimulate the Wnt pathway [50] and down-regulate
PPARg expression in lung fibroblasts [18-20,31,32].
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Figure 8 Effect of perinatal nicotine exposure on markers of differentiation in fibroblasts isolated from the lungs of F2 rats (mixed
gender). Compared to the control group, with nicotine administration the expression of fibronectin increased and that of PPARg decreased, at
both the protein (A) and mRNA (B) levels. Values are means ± SE. n = 3 for each group. * P < 0.05, versus control group. GAPDH, glyceraldehyde
3-phosphate dehydrogenase; PPARg, peroxisome proliferator-activated receptor gamma.
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The compelling epigenetic data presented here poten-
tially shift the current paradigm for our understanding of
childhood asthma, and for the first time implicate epige-
netics as the underlying cause for increased MG asthma
following in utero exposure to maternal smoking. In fact,
the data provided herein not only provide novel mechan-
istic information underlying the MG asthma risk, but
also pave the way for studying the molecular mechanisms
underlying MG effects for a host of other environmental
toxins, agonists and antagonists as well.
It is important to point out that although there are
many agents in cigarette smoke that may be detrimental
to the developing lung, there is plenty of evidence to
support nicotine as the main agent that alters fetal lung
development: nicotine crosses the human placenta with
minimal biotransformation [51]; it accumulates in fetal
blood, maternal milk, amniotic fluid, and several fetal
tissues, including the respiratory tract [52-54], and has
been shown to have direct effects on pulmonary alveolar
epithelial cells and interstitial fibroblasts isolated from
the developing lung [32,43,55-60]. Therefore, it is not
surprising that nicotine exposure during pregnancy is an
extensively utilized and well-accepted model to study
the effects of cigarette smoke on the developing lung in
general, and on asthma in particular [18,20]. It is also
important to emphasize that the main effects of in utero
nicotine exposure on lung growth and development are
due to specific alterations in signaling pathways involved
in lung development [18,20,31,32,55-60], rather than
being due to irreversible disruption by teratogenic or
toxicological effects. This feature offers the opportunity
for targeted interventions to modulate the effects of in
utero nicotine exposure, in contrast to toxic or teratolo-
gic effects, which would be unlikely to be effectively
blocked by any intervention.
It could be argued that the epigenetic marks in the gonads
and lung are epiphenomena, and that the RGZ ‘rescue’ of
the normal lung phenotype is an artifact. However, there is
experimental evidence that methylation of H3/H4 results in
down-regulation of PPARg expression [61], mechanistically
linking the epigenetic effect of nicotine with decreased
lipofibroblast expression [18] and asthma [20].
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Figure 9 Effect of rosiglitazone (RGZ) in perinatal nicotine exposure-induced changes in global DNA methylation and histone (H) 3
and 4 acetylation in the lungs and gonads of F1 rats. Compared to the control group, with nicotine administration the level of global DNA
methylation increased in the testes, decreased in the ovaries, but did not change in the lungs (A); H3 acetylation increased in the lungs and
testes, but did not change in the ovaries (B); H4 acetylation decreased in the lungs, while it increased in the testes and ovaries (C). Most of
these changes were blocked by concomitant RGZ administration. For example, in the lungs the nicotine-induced increase in lung H3 acetylation
was blocked by RGZ, whereas there was no effect on global DNA methylation or on the nicotine-induced decrease in H4 acetylation; in the
testes, the nicotine-induced increase in DNA methylation and H4 acetylation were blocked, without any effect on H3 acetylation; and in the
ovaries, the nicotine-induced decrease in DNA methylation and increase in H4 acetylation were blocked without any effect on H3 acetylation.
Values are means ± SE with variable numbers for each group. *P < 0.05, **P < 0.01, versus control; n = 4 to 6.
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Conclusions
From the data included here we conclude that the pulmon-
ary effects of nicotine exposure during pregnancy are not
restricted only to the offspring of the exposed pregnancy,
but are also transmitted to subsequent generation, possibly
through germline epigenetic alterations, and, even more
importantly, these effects can be blocked by targeted mole-
cular interventions. Moreover, these data not only provide
novel mechanistic information underlying the multigenera-
tion transmission of asthma risk following exposure to
maternal smoke during pregnancy, but also set precedence
for studying other such environmental toxins that might
have multigenerational or transgenerational effects.
Additional material
Additional File 1: Rat Model of Multigenerational Nicotine-induced
Asthma. Rats were exposed to nicotine in utero (F0) to mimic maternal
cigarette smoking. F0 offspring were then mated to generate F1
offspring, which in turn were mated to generate F2 offspring. Lungs,
ovaries and testes are shown in black or white to symbolize direct or
multigenerational nicotine exposure effects, respectively.
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Figure 10 Effect of perinatal rosiglitazone exposure on global lung and gonadal DNA methylation and histone (H) 3 and 4 acetylation
in F1 rats. With perinatal rosiglitazone exposure alone during gestation there was no effect on global DNA methylation and H3 and H4
acetylation in the lungs and gonads of F1 rat pups. Values are means ± SE; n = 4 to 6.
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